chartexchange

SOPHiA GENETICS Partners Myriad Genetics To Advance Prostate Genomic Instability Score Technology

RTTNews | Oct 8, 2026 9:29 AM EDT


(RTTNews) - SOPHiA GENETICS (SOPH) and Myriad Genetics, Inc. (MYGN) announced Thursday a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (AZN).

Read original article